Sanjiv Sam Gambhir
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Sanjiv Sam Gambhir sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).
Sanjiv Sam Gambhir: 3 sponsored US clinical trials, none currently recruiting.
Sanjiv Sam Gambhir sponsors 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 2 completed. 0 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, with 1 trials.
Upper-quartile sponsor footprint
Sanjiv Sam Gambhir sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
3 total, page 1 of 1
Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian and Breast Cancer
NCT02708511
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
NCT01806675
Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis
NCT00185848
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
Therapeutic Areas
How the Sanjiv Sam Gambhir early-phase archive is shaped
3 indexed studies, none listed as recruiting (0% open); 2 completed (67%).
Phase mix: 0 late (III/IV) vs 3 early (I/II) (early-phase heavy).
Top condition: Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity (1 trial), 9 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Sanjiv Sam Gambhir: archived-pipeline peers nationwide
Peers matched on 3 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Sanjiv Sam Gambhir sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 3 archived trials
- 10xBio · 3 trials · 0% recruiting
- 22nd Century Group · 3 trials · 0% recruiting
- AA Secord · 3 trials · 0% recruiting
- AAADRS Clinical Research Center · 3 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
- 3EO Health · 0% recruiting · 2 trials
Related
What to do with this Sanjiv Sam Gambhir page
3 registered trials is a research-attention snapshot, not an endorsement of Sanjiv Sam Gambhir or any single study.
- None of Sanjiv Sam Gambhir's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity is the condition Sanjiv Sam Gambhir studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Sanjiv Sam Gambhir pipeline card: 3 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.